ANN ARBOR STAGE II GRADE 1 FOLLICULAR LYMPHOMA
Clinical trials for ANN ARBOR STAGE II GRADE 1 FOLLICULAR LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new ANN ARBOR STAGE II GRADE 1 FOLLICULAR LYMPHOMA trials appear
Sign up with your email to follow new studies for ANN ARBOR STAGE II GRADE 1 FOLLICULAR LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can adding an immune booster to radiation keep lymphoma away longer?
Disease control OngoingThis study compares radiation therapy alone versus radiation plus rituximab (a drug that helps the immune system attack cancer) for patients with early-stage (I or II) low-grade follicular lymphoma. The goal is to see if the combination keeps the cancer from progressing longer. A…
Matched conditions: ANN ARBOR STAGE II GRADE 1 FOLLICULAR LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 16, 2026 12:53 UTC
-
Tiny radiation dose may tame eye lymphoma
Disease control OngoingThis study tests whether a very low dose of radiation (4 Gy) can control slow-growing B-cell lymphoma in the eye socket. About 50 adults with stage I-IV indolent lymphoma or mantle cell lymphoma will receive this targeted treatment. The goal is to shrink or stop the cancer while …
Matched conditions: ANN ARBOR STAGE II GRADE 1 FOLLICULAR LYMPHOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 15, 2026 19:07 UTC